Have your own idea? Try our Stock Screener
UPDATED Nov 23, 2024
Discover Swiss High Yield Dividend Stocks that are on the SMI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
TECN | CHF 210.00 | 0.2% | -32.8% | CHF 2.7b | CHF 286.14 | PE26.6x | E14.9% | 1.4% | Pharmaceuticals & Biotech | ||
SIKA | CHF 231.40 | -1.7% | -2.5% | CHF 37.1b | CHF 288.67 | PE29.8x | E8.9% | 1.4% | Materials | ||
LISN | CHF 99,000.00 | 1.0% | -8.0% | CHF 23.0b | CHF 110,057.69 | PE33.5x | E6.3% | 1.4% | Food, Beverage & Tobacco | ||
SOON | CHF 312.10 | -1.0% | 24.7% | CHF 18.6b | CHF 296.28 | PE32.9x | E11.2% | 1.4% | Healthcare | ||
SQN | CHF 337.40 | 2.4% | 66.5% | CHF 5.0b | CHF 310.50 | PE19.6x | E12.7% | 1.3% | Diversified Financials | ||
RSGN | CHF 20.10 | -4.3% | 103.0% | CHF 561.4m | CHF 20.95 | PE60.6x | S28.5% | 1.2% | Capital Goods | ||
BANB | CHF 67.50 | -2.0% | -4.3% | CHF 5.1b | CHF 84.43 | PE44.6x | E17.9% | 1.2% | Pharmaceuticals & Biotech | ||
DOKA | CHF 671.00 | -0.9% | 45.2% | CHF 2.8b | CHF 668.75 | PE66.6x | E34.8% | 1.1% | Capital Goods | ||
SDZ | CHF 40.60 | 1.1% | 53.8% | CHF 17.8b | CHF 41.71 | PS2x | E34.5% | 1.1% | Pharmaceuticals & Biotech | ||
VILN | CHF 595.00 | 0% | -2.5% | CHF 62.1m | n/a | PE36x | n/a | 0.8% | Consumer Retailing | ||
LONN | CHF 521.40 | 1.8% | 48.8% | CHF 37.7b | CHF 631.85 | PE65.7x | E23.9% | 0.8% | Pharmaceuticals & Biotech | ||
STMN | CHF 111.50 | 0.6% | -8.7% | CHF 17.8b | CHF 131.12 | PE61.8x | E20.9% | 0.8% | Healthcare | ||
YPSN | CHF 357.00 | -1.9% | 21.6% | CHF 4.9b | CHF 426.00 | PE65.5x | E41.1% | 0.6% | Healthcare | ||
SKAN | CHF 73.10 | 0% | -9.9% | CHF 1.6b | CHF 90.00 | PE51x | E18.7% | 0.5% | Pharmaceuticals & Biotech | ||
MOVE | CHF 110.80 | -1.9% | -5.9% | CHF 2.2b | CHF 139.86 | PE42.2x | E18.4% | 0.5% | Healthcare | ||
COTN | CHF 277.00 | -0.7% | 19.4% | CHF 2.2b | CHF 370.71 | PE123x | E48.6% | 0.4% | Tech | ||
SFZN | CHF 1,114.00 | 3.7% | 40.2% | CHF 4.8b | CHF 1,187.67 | PE37.1x | E13.6% | 0.3% | Pharmaceuticals & Biotech | ||
ALC | CHF 76.68 | 2.1% | 18.6% | CHF 37.9b | CHF 87.78 | PE36.5x | E9.8% | 0.3% | Healthcare | ||
ELMN | CHF 1,050.00 | 1.0% | 2.9% | CHF 239.9m | n/a | PE26.8x | n/a | 0.2% | Tech | ||
DCN | CHF 750.00 | 0% | 7.1% | CHF 120.6m | n/a | PE12.5x | n/a | 0% | Tech | ||
ARBN | CHF 11.30 | -6.1% | 33.6% | CHF 784.8m | CHF 15.07 | PE48x | E-29.6% | 0% | Capital Goods | ||
TIBN | CHF 38.20 | -1.8% | -8.0% | CHF 128.4m | CHF 48.00 | PE7.6x | S3.6% | 0% | Consumer Services | ||
PEAN | CHF 10.68 | 13.1% | -2.9% | CHF 242.7m | CHF 13.80 | PS2x | E104.0% | 0% | Real Estate Management and Development | ||
PPGN | CHF 27.95 | -3.0% | 48.9% | CHF 921.9m | CHF 36.25 | PS3.1x | E64.2% | 0% | Pharmaceuticals & Biotech |